Inogen Gets FDA Clearance For Home Oxygen Concentrator Inogen At Home

(RTTNews) - Inogen Inc. (INGN) announced Tuesday that it has received FDA clearance for home oxygen concentrator called the Inogen At Home.

According to the company, the Inogen At Home is expected to be the lightest 5 liter per minute continuous flow oxygen concentrator on the market, when it is released for sale later this year. At approximately 18 pounds, the Inogen At Home will be more than 10 to 20 pounds lighter than current oxygen concentrators from leading manufacturers with equivalent flow capacity.

Additionally, the Inogen At Home is expected to have the lowest power consumption of any 5 liter per minute continuous flow oxygen concentrator on the market, which should reduce the electricity cost for oxygen therapy patients. Other advancements made in the product include size and noise level reductions.

The Inogen At Home is planned to be released for sale later this year.